EGRX stock forecast for 2023 – 2027
Last updated: April 19, 2024
Are you interested in Eagle Pharmaceuticals, Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the EGRX stock price in 2022-2027. Is EGRX a good long term stock? When should I take profit in Eagle Pharmaceuticals stock? Buy or sell stock? Will EGRX stock price go up? What are analysts’ forecasts for EGRX stock?
Forecst.com predicts future values using technical analysis of a large number of analytical parameters. EGRX stock returns are also predicted based on historical data.
According to our research, EGRX stock is a bad long-term investment. EGRX share price has been in a bear cycle for the past year. Eagle Pharmaceuticals, Inc. stock trend is negative.
Eagle Pharmaceuticals company info
| Industry | Drug Manufacturers—Specialty & Generic |
| Address | 50 Tice Boulevard, Woodcliff Lake, NJ, 07677, United States |
| Website | https://www.eagleus.com |
Forecasting
52 Week High: 51.8763 USD
52 Week Low: 40.4613 USD
1 Year Forecast: 40.0526 USD
5 Year Forecast: 0 USD
Agilent Technologies info
Market Cap: 595.07M
52 Week Change: -3.824%
52 Week High: 58.25 USD
52 Week Low: 36.48 USD
Beta: 0.691518
50 Day Moving Average: 50.06
90 Day Moving Average: 49.814
200 Day Moving Average: 50.52
Resistance Level: 47.776
Pivot Point: 46.2449
Support Level: 44.8672
Enterprise Value: 597,318,016
Forward P/E: 6.16
Forward EPS: 7.37
Profit Margin: 3.14%
Shares Outstanding: 12,913,900
EBITDA: 77.18
Held Percent Institutions: 94.55%
PEG Ratio (5Y): 7.42
Trailing EPS: 0.43
Eagle Pharmaceuticals stock forecasts for 2023-2027
| Date | Open Price | Close Price | Change |
Eagle Pharmaceuticals Stock Forecast for 2023 | |||
| January 2023 | 45.54 | 40.59 | -10.87% |
| February 2023 | 40.4 | 44.88 | 11.09% |
| March 2023 | 44.44 | 40 | -9.99% |
| April 2023 | 40 | 41.16 | 2.9% |
| May 2023 | 43 | 44.88 | 4.37% |
| June 2023 | 44 | 45.54 | 3.5% |
| July 2023 | 46.92 | 45 | -4.09% |
| August 2023 | 44.1 | 42.14 | -4.44% |
| September 2023 | 42.14 | 42.14 | 0% |
| October 2023 | 43.43 | 39.6 | -8.82% |
| November 2023 | 40.4 | 42.42 | 5% |
| December 2023 | 42 | 41.41 | -1.4% |
Eagle Pharmaceuticals Stock Forecast for 2024 | |||
| January 2024 | 41.41 | 35.28 | -14.8% |
| February 2024 | 35.28 | 39.78 | 12.76% |
| March 2024 | 38.61 | 34.65 | -10.26% |
| April 2024 | 34.65 | 37.62 | 8.57% |
| May 2024 | 37.24 | 38.61 | 3.68% |
| June 2024 | 38.61 | 41.82 | 8.31% |
| July 2024 | 42 | 39.2 | -6.67% |
| August 2024 | 40.4 | 38 | -5.94% |
| September 2024 | 38.76 | 39.39 | 1.63% |
| October 2024 | 39 | 36.36 | -6.77% |
| November 2024 | 35.28 | 37.74 | 6.97% |
| December 2024 | 36.26 | 37.74 | 4.08% |
Eagle Pharmaceuticals Stock Forecast for 2025 | |||
| January 2025 | 37 | 31 | -16.22% |
| February 2025 | 30.69 | 33.66 | 9.68% |
| March 2025 | 33.32 | 30.6 | -8.16% |
| April 2025 | 29.4 | 33 | 12.24% |
| May 2025 | 33.66 | 33.32 | -1.01% |
| June 2025 | 33.66 | 36.63 | 8.82% |
| July 2025 | 37.74 | 36.72 | -2.7% |
| August 2025 | 35.7 | 33.66 | -5.71% |
| September 2025 | 32.34 | 34.68 | 7.24% |
| October 2025 | 34.34 | 31.31 | -8.82% |
| November 2025 | 31 | 32 | 3.23% |
| December 2025 | 31.68 | 31.68 | 0% |
Eagle Pharmaceuticals Stock Forecast for 2026 | |||
| January 2026 | 31.68 | 27 | -14.77% |
| February 2026 | 25.74 | 29 | 12.67% |
| March 2026 | 29 | 25.74 | -11.24% |
| April 2026 | 26.26 | 29.58 | 12.64% |
| May 2026 | 28.42 | 30.3 | 6.62% |
| June 2026 | 29.4 | 31.68 | 7.76% |
| July 2026 | 32.32 | 30.38 | -6% |
| August 2026 | 30.3 | 28.71 | -5.25% |
| September 2026 | 28.42 | 28.71 | 1.02% |
| October 2026 | 28.71 | 25.74 | -10.34% |
| November 2026 | 26.52 | 28.28 | 6.64% |
| December 2026 | 28.28 | 27.27 | -3.57% |
Eagle Pharmaceuticals Stock Forecast for 2027 | |||
| January 2027 | 27 | 22.22 | -17.7% |